We subcutaneously inoculated mice with MC38-OVA, a colon cancer cell line that overexpresses ovalbumin, which could activate CD8+ T cells in mice, to confirm that the strong anti-tumour phenotype of Rig-I−/− mice depends on the anti-tumour specificity of CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.